FDA chief looks to speed diabetes, obesity drugs

FDA chief looks to speed diabetes, obesity drugs
Mark McClellan, commissioner of the Food and Drug Administration, said he wants to apply a fast-track review process normally reserved for drugs for terminal cancer and AIDS patients to drugs for diabetes and obesity.

Click here for reuse options!
Copyright 2003 Biotechblog

Leave a Reply

%d bloggers like this: